Join to View Full Profile
560 1st Avenue2nd Floor Energy BuildingNew York, NY 10016
Dr. Cooney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Cooney is a Radiation Oncologist based in New York, NY, working at NYU Langone Health since 2021. He earned his MD and PhD from The University of Texas Health Science Center at San Antonio through the South Texas Medical Scientist Training Program. Dr. Cooney also holds a B.S. in Biology from Boston College. He has held past positions as a physician at Grandview Medical Center and a research associate at both The University of Texas Health Science Center and Brigham and Women's Hospital. His research has been published multiple times, with articles cited as many as 90 times. Dr. Cooney has received several accolades, including the South Texas MSTP Annual Retreat First-place Oral Presentation Award and the Barbara Bowman Student of the Year Award.
Education & Training
South Texas Medical Scientist Training ProgramMD/PhD, Cancer Biology, 2012 - 2020
The University of Texas Health Science Center at San AntonioClass of 2020, MD- University of Texas Health Science Center at San AntonioPhD, Cell and Structural Biology, 2014 - 2018
- Boston CollegeB.S., Biology, 2005 - 2009
Awards, Honors, & Recognition
- South Texas MSTP Annual Retreat First-place Oral Presentation Award South Texas MSTP, 2018
- Barbara Bowman Student of the Year Award UT Health San Antonio, 2018
- Rennels Memorial Award for Excellence in Graduate Studies UT Health San Antonio, 2017
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsSynergistic Targeting of the Regulatory and Catalytic Subunits of PI3Kδ in Mature B-cell Malignancies.Jeffrey D. Cooney, An Ping Lin, Daifeng Jiang, Long Wang, Avvaru N. Suhasini
Clinical Cancer Research. 2017-12-15 - 21 citationsPhosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignanciesJeffrey D. Cooney, Ricardo C.T. Aguiar
Blood. 2016-12-22 - 54 citationsTMEM14C is required for erythroid mitochondrial heme metabolism.Yvette Y. Yien, Raymond F. Robledo, Iman J. Schultz, Naoko Takahashi-Makise, Babette Gwynn
The Journal of Clinical Investigation. 2014-10-01
Press Mentions
M.D./Ph.D. student co-authors paper in NatureApril 9th, 2020
M.D./Ph.D. students, Baptist nursing students celebrate Adler family’s gift of $1.5 millionDecember 1st, 2020
Stand Up To Cancer Funds AI Research, Damon Runyon Cancer Research Foundation Research Fellows Announced, and moreDecember 1st, 2020
Grant Support
- The Cyclic AMP/Phosphodiesterase-4 Axis Regulates Proximal B Cell Receptor Signaling And Offers A New Therapeutic Strategy For B Cell LymphomasNational Cancer Institute F30 NRSA Predoctoral Fellowship2016–2020
- Undergraduate Student Summer Research FellowshipAmerican Heart Association2009
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
